Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06684457 · ClinicalTrials.gov registry record · NA

Patient Perceived Empathy of an AI Chatbot for Atrial Fibrillation Education

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT06684457 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06684457, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

Atrial Fibrillation is a chronic disease with significant health consequences like increased risk of stroke, heart failure, heart attack and death. Educating patients about the disease is important for them to be able to understand the condition better, feel empowered and take an active part in their care plan. AI technology can potentially be used to impart such education. However, doing so with care and empathy is equally important. Therefore, it is necessary to ensure when AI technology is used to impart education about atrial fibrillation to patients, the humane aspects of the interaction are rigorously tested. This study examines a way to impart atrial fibrillation education through interaction with an AI chatbot, that uses text and links to educational videos. To participate in this study, people need to be age 18 or older and have a history of newly diagnosed atrial fibrillation. Approximately 40 individuals will be asked to take part in this study. The first step to the study will be reading through, understanding, and signing an informed consent. People who then agree to join the study will have a one-time interaction with the AI chatbot and structured educational material by using an iPad provided to them for the approximately 1 hour duration of the study. People in the study will obtain atrial fibrillation education by typing one by one on the iPad, up to 10 questions about the disease. Answers will include text and links to videos. Before and after atrial fibrillation education, people who join this study will be asked to fill out a survey. The study team will teach patients how to use the iPad and type in questions.

Interventions

  • BEHAVIORAL Atrial Fibrillation Education

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-11-25
Est. Completion 2025-05-02
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT06684457

The ClinicalTrials.gov registry entry for NCT06684457 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Atrial Fibrillation Education is the first listed.

NCT06684457 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06684457 about?

NCT06684457 is a clinical study titled "Patient Perceived Empathy of an AI Chatbot for Atrial Fibrillation Education". Atrial Fibrillation is a chronic disease with significant health consequences like increased risk of stroke, heart failure, heart attack and death. Educating patients about the disease is important for them to be able to understand the condition better, feel empowered and take an active part in thei...

What is the current status of trial NCT06684457?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2024-11-25. Estimated completion is 2025-05-02.

What interventions are being tested in trial NCT06684457?

The interventions under investigation include: Atrial Fibrillation Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT06684457?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.